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Abstract
The human microbiome can contribute to the pathogenesis of many complex dis-
eases such as cancer and Alzheimer’s disease by mediating disease-leading causal
pathways. However, standard mediation analysis is not adequate in the context of
microbiome data due to the excessive number of zero values in the data. Zero-valued
sequencing reads, commonly observed in microbiome studies, arise for technical
and/or biological reasons. Mediation analysis approaches for analyzing zero-inflated
mediators are still lacking largely because of challenges raised by the zero-inflated
data structure: (a) disentangling the mediation effect induced by the point mass at
zero; and (b) identifying the observed zero-valued data points that are actually not
zero (i.e., false zeros). We develop a novel mediation analysis method under the
potential-outcomes framework to fill this gap. We show that the mediation effect of
the microbiome can be decomposed into two components that are inherent to the
two-part nature of zero-inflated distributions. The first component corresponds to
the mediation effect attributable to a unit-change over the positive relative abun-
dance and the second component corresponds to the mediation effect attributable
to discrete binary change of the mediator from zero to a non-zero state. With
probabilistic models to account for observing zeros, we also address the challenge
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with false zeros. A comprehensive simulation study and the applications in two real
microbiome studies demonstrate that our approach outperforms existing mediation
analysis approaches.
1 Introduction
Emerging evidence suggest that the human microbiome and the immune system are con-
stantly shaping each other [4]. Thus the human microbiome can contribute to disease
pathogeneses by mediating disease-leading causal pathways in complex diseases such as
Alzheimer’s disease [46] and cancer [21, 36]. To quantitatively study human microbiome,
16S ribosomal RNA gene sequencing and metagenomic shotgun sequencing have been
popular methods to quantify microbiome composition in microbiome studies. An impor-
tant feature of microbiome sequencing data is that it has excessive number of zeros [23].
Many microbiome data sets have more than 50% datapoints equal to 0, and it could be
as high as 80% or more. These zeros are likely to be a mixture of structural zeros (i.e.,
true zeros) that represent true absence of microbial taxa and undersampling zeros (i.e.,
false zeros) that result from failure of detection. The zero-inflated data feature poses a
challenge that needs to be addressed specifically in mediation analysis. Although there
have been some exciting efforts to model microbiome as a high-dimensional mediator
[34, 44, 48, 49], it remains a daunting task to address the zero-inflated data structure in
mediation analyses.
Mediation analysis is an important tool to investigate the role of intermediate vari-
ables (i.e., mediators) in a causal pathway where the causal effect partially or completely
relies on the mediators. For example, people with higher socioeconomic status tend to
have longer life expectancy, but this causal pathway may be explained by many possible
mediators including access to better health care, fewer stressors, better living environ-
ment and so forth. In a mediation analysis, the indirect effect (i.e., mediation effect)
through one or more mediators can be estimated and tested along with the direct effect.
This technique was first popularized in psychology and social sciences where traditional
linear mediation analysis was proposed, and now is a common tool in many research ar-
eas such as epidemiology, environmental health sciences, medicine, randomized trials and
psychiatry. Mediation analysis is a powerful approach largely because of its capability
to estimate and test the mediation effect that cannot be achieved with typical regression
approaches. There are two general types of mediation analysis approaches: potential-
outcomes (PO) or counterfactual-outcomes methods [19, 40, 41] and traditional linear
mediation analysis methods [3, 26]. The former approach stems from a counterfactual
nonparametric function of a causal relationship without relying on linear assumptions
and the latter is based on linear regression models. These approaches coincide with each
other under linearity assumptions. PO approaches are more flexible because they can
allow interaction effects of the exposure/treatment variable (referred to as exposure vari-
able hereafter) with mediators as well as nonlinear effects to be modeled. It is worth
noting that assumptions on unmeasured and measured confounders are required to draw
causal inference regardless of which type of mediation analysis approach is used. Reviews
of mediation analysis approaches and their assumptions can be found in the literature
[22, 27, 42].
Although mediation modeling frameworks have been well established, to the best of
our knowledge, there have been few studies which address the zero-inflated distributions
for mediators. In a typical mediation analysis, the total effect of an exposure variable
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can be decomposed into a mediation effect and a direct effect where the mediation effect
measures the amount of the total causal effect attributable to change in the mediator
caused by the exposure variable and the direct effect measures the causal effect due to
change in the exposure variable while keeping the mediator variable constant. When the
mediator has a zero-inflated distribution such as a zero-inflated Beta (ZIB) distribution
or any other zero-inflated distributions, we show that its mediation effect can be further
decomposed into two parts with one part being the mediation effect attributable to the
amount of numeric change in the mediator and the other part being the mediation effect
attributable to the binary change of the mediator from zero to a non-zero state. This
phenomenon can be explained by the two-part nature of a zero-inflated distribution. For
example, a ZIB distribution is essentially a two-component mixture distribution [13]: one
component is a degenerate distribution with probability mass of one at zero, and the
other component is a Beta distribution. The mediator changing from zero to a positive
value results in the discrete jump from zero to a non-zero state as well as the change
in the numerical metric of the mediator and thus the mediation effect can be divided
accordingly. Both changes have important consequences as we can see in the real study
examples later where the absence of a microbial taxon and the abundance level of a
microbial taxon given its presence are considered. What makes it more complicated is
that the observed zero-valued data points could be false zeros meaning that the true
values are non-zero but observed as zero due to failure of detection. This is similar to a
missing data problem and will be addressed here as well.
To fill the research gap in mediation modeling development, we propose a novel medi-
ation analysis approach under the PO framework to model mediators with zero-inflated
distributions. This approach can allow a mixture of truly zero-valued datapoints and
false zeros. Our method is able to decompose the mediation effect into two components
that are inherent to zero-inflated mediators: one component is the mediation effect at-
tributable to the numeric change of the mediator on its continuum scale and the other
component is the mediation effect attributable to the binary change of the mediator from
zero to a non-zero state. So the mediation effect is actually the total mediation effect of
the two components each of which can be estimated and tested. Although we focused on
ZIB distribution for microbial taxa, our approach has a general framework to accommo-
date many zero-inflated distributions. A simulation study is conducted to evaluate our
approach in comparison with a standard PO mediation analysis approach and two other
existing approaches that can analyze microbiome composition as a mediator.
We introduce the model and its associated notations in Section 2. Estimation and
inference procedures are provided in Section 3. A simulation study to assess the perfor-
mance of our model in comparison with existing approaches is presented in Section 4,
followed by an application of our model in two real studies in Section 5, and a discussion
in Section 6. Additional details and derivations can be found in the Appendix.
2 Model and Notation
For simplicity, we suppress subject index in all notations in this section. Let Y , M and
X denote the continuous outcome variable, the mediator variable and the independent
variable respectively. We assume the outcome Y depend on M and X through the
following regression equation:
Y = β0 + β1M + β21(M>0) + β3X + β4X1(M>0) + β5XM +  (1)
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where 1(·) is an indicator function, the random error  follows a normal distribution
N(0, δ), and β1, β2, β3, β4 and β5 are regression coefficients. The mediator M represents
relative abundance (RA) of a microbial taxon for microbiome data. The advantage of
using M instead of log (M), which has been used the literature [34, 44], is that we do not
need to impute zero values of M with an positive number.
In order to construct a mediation model, we also need to model the association between
M and X. For the zero-inflated mediator M , we write its distribution into a mixture
distribution with the two-part density function given by:
f(m; θ) =
{
G(θ), m = 0
(1− G(θ))G(m; θ), m > 0
where θ is the K-dimensional parameter vector associated with the zero-inflated distri-
bution, G(·) is a RK → R mapping with 0 < G(θ) < 1 being the probability of M taking
the value of 0 and G(m; θ) is the conditional probability density (or mass) function of M
given that M is positive. We use a ZIB distribution [10, 11] for M when modeling relative
abundance (RA) of microbial taxa as the mediator. This two-part model is fairly general
and can model other parametric zero-inflated distributions as well, such as zero-inflated
log-normal distribution and zero-inflated Poisson distribution. With this formulation, we
can model the association beween M and X by assuming the parameter θ depends on X
through the following equation:
T (θ) = ν0 + ν1X (2)
where T : RK → RK is a known one-to-one (possibly nonlinear) transformation of the
parameter vector θ, and ν0 and ν1 are two K-dimensional parameters where ν0 can be
interpreted as the intercept vector and ν1 as the slope vector.
Equations (1) and (2) together form our full mediation model. Notice that X is a
scalar here, but it is obvious that other covariates such as potential confounders can be
included in the two equations. This model is fully compatible with allowing interactions
between the exposure variable and mediators as the two interaction terms: X1(M>0)
and XM are included in equation (1). In practice, investigators can also include only
one or no interaction term depending on the hypothesis of interest. Notice that it will
be challenging for traditional linear mediation methods to estimate the mediation effect
here because of: 1) the interaction terms: β4X1(M>0) and β5XM ; 2) the term β21(M>0)
in equation (1) which is a nonlinear function of the mediator M .
More specifically for a ZIB mediator, the two-part density function can be written as:
f(m; θ) =
G(θ), m = 0(1− G(θ))mµφ−1(1−m)(1−µ)φ−1
B
(
µφ,(1−µ)φ
) , m > 0
where θ = (µ, φ,∆)T , G(θ) = ∆, B(·, ·) is the Beta function and µ and φ are the mean
and dispersion parameters respectively of the Beta distribution for the non-zero part
[12, 16]. To model the association of the mediator with X, we use T (θ) = (log(µ/(1 −
µ)), log(φ), log(∆/(1−∆))T , ν0 = (α0, ξ, γ0)T and ν1 = (α1, 0, γ1)T and thus equation (2)
becomes the following three equations:
log
( µ
1− µ
)
= α0 + α1X, (3)
4
log(φ) = ξ, (4)
log
(
∆
1−∆
)
= γ0 + γ1X, (5)
where the dispersion parameter φ is assumed not to depend on X which is why the right-
hand side of equation (4) does not involve X. More details on formulation of the model
are provided in the Appendix.
2.1 Mechanism for observing zeros of the mediator
For microbiome abundance data, observations below the limit of detection are set to be
zero. Consequently, there are two types of zeros in the observed abundance data: true
abundance of zero (i.e., absence) and abundance that is reported as zero as a consequence
of the measurement procedure. We will use real microbiome studies to illustrate our
method in a later section. Let M be the relative abundance of a microbial taxon and let
M∗ denote the observed value of M . When the observed value is positive (i.e., M∗ > 0),
we assume that M∗ = M . But when M∗ = 0, we don’t know whether M is truly zero or
M is positive but observed as zero. We consider the following mechanism for observing
a zero of the microbial taxon abundance:
P (M∗ = 0|M,L) = 1(ML<1), (6)
where L is the library size (i.e., sequencing depth) and the product ML can be interpreted
as the sample absolute abundance (SAA) of the taxon in a sample. Under this mechanism,
all SAA below 1 have an observed value of zero. Here 1 can be considered as the Limit
of Detection (LOD). We refer to this mechanism as ”LOD mechanism” hereafter. This
mechanism assumes that the probability of observing a zero only depends on SAA which
implies that it is independent of the outcome Y conditional on SAA. Since SAA depends
on both L and M , the LOD mechanism is not deterministic conditional on the library
size. The probability of observing a zero conditional on L, the library size, is equal to
E(1(ML<1)|L) = P (M < 1/L).
2.2 Mediation effect and direct effect
Under the potential-outcomes (PO) framework [42], we can define the natural indirect
effect (NIE), natural direct effects (NDE) and controlled direct effect (CDE) where NIE is
the mediation effect. The total effect of the exposure variable X is equal to the summation
of NIE and NDE. Let Mx denote the value of M if X equals x. Let Yxm denote the value
of Y if (X,M) = (x,m). The average NIE, NDE and CDE for X changing from x1 to x2
are defined as:
NIE = E
(
Yx2Mx2 − Yx2Mx1
)
NDE = E
(
Yx2Mx1 − Yx1Mx1
)
CDE = E
(
Yx2m − Yx1m
)
, for a fixed (i.e., controlled) value of M,
where Yx2Mx1 is a counterfactual outcome. By plugging the equations (1)-(2) into the
above definitions and using Riemann-Stieljes integration [37], we can obtain the following
formulas:
NIE = E(Yx2Mx2 )− E(Yx2Mx1 ) = E(E(Yx2Mx2 |Mx2))− E(E(Yx2Mx1 |Mx1))
= E(β0 + β1Mx2 + β21(Mx2>0) + β3x2 + β4x21(Mx2>0) + β5x2Mx2)
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− E(β0 + β1Mx1 + β21(Mx1>0) + β3x2 + β4x21(Mx1>0) + β5x2Mx1)
= (β1 + β5x2)(E(Mx2)− E(Mx1)) + (β2 + β4x2)(E(1(Mx2>0))− E(1(Mx1>0)))
= NIE1 + NIE2,
NIE1 = (β1 + β5x2)(E(Mx2)− E(Mx1))
= (β1 + β5x2)
( ∫
m∈Ω
mdFMx2 (m)−
∫
m∈Ω
mdFMx1 (m)
)
= (β1 + β5x2)(1− G(θx2))
∫
m∈Ω\0
mG(m; θx2)dm
− (β1 + β5x2)(1− G(θx1))
∫
m∈Ω\0
mG(m; θx1)dm),
NIE2 = (β2 + β4x2)(G(θx1)− G(θx2)),
NDE = E
(
Yx2Mx1 − Yx1Mx1
)
= E
(
Yx2Mx1
)− E(Yx1Mx1)
= β3(x2 − x1) + β4(x2 − x1)(1− G(θx1)) + β5(x2 − x1)E(Mx1)
= β3(x2 − x1) + β4(x2 − x1)(1− G(θx1)) + β5(x2 − x1)
∫
m∈Ω
mdFMx1 (m)
= β3(x2 − x1) + β4(x2 − x1)(1− G(θx1))
+ β5(x2 − x1)(1− G(θx1))
∫
m∈Ω\0
mG(m; θx1)dm
CDE = β3(x2 − x1) + β4(x2 − x1)1(m>0) + β5m(x2 − x1),
where Ω denotes the domain of the mediator M , Mx denotes the value of M conditional
on X = x, FMx(m) denotes the CDF of Mx, dFMx(m) denotes the stieltjes integration [37]
with respect to FMx(m), θx = T
−1(ν0 + ν1x), Ω \ 0 denotes the subset of Ω that does not
contain 0, and T−1(·) denotes the inverse function of T (·). NIE, NIE1, NIE2, NDE and
CDE can be estimated by plugging the parameter estimates into the formulas. Confidence
intervals (CI) can be obtained using the delta method. An alternative approach for finding
standard errors to construct CI is bootstrapping [14]. More details of the calculation for
mediation effect and direct effect and their CI for ZIB mediators can be found in the
Appendix. NIE1 can be interpreted as the mediation effect due to the change of the
mediator on its numeric scale and NIE2 can be interpreted as the mediation effect due
to the discrete binary change of the mediator from zero to a non-zero status. This
decomposition can be also seen in Figure 1 where there are two possible indirect causal
pathways from X to Y through the mediator M . When the distribution of mediator is
not zero-inflated, NIE2 becomes 0 since G(θx) reduces to 0, and thus the NIE reduces to
a usual NIE that can be calculated by standard approaches [19, 40].
3 Parameter Estimation
Maximum likelihood estimation (MLE) will be used to estimate the parameters. The
variables of observed data for each subject can be denoted by the vector (Y,R,M∗, L,X)
where R = 1(M∗>0) and the subject index is suppressed. We are not considering other
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Figure 1: Potential causal mediation pathways of a zero-inflated mediator.
covariates here, but the method can be easily extended to include more covariates in the
equations (1)-(2). The estimation challenge is that M is not always observable due to
false zeros. The log-likelihood contribution from those subjects with false zeros cannot be
directly calculated. However, given that we know the probability of observing a zero in
equation (6), we can still obtain their log-likelihood contributions by integrating the joint
density function over all possible values of M using Riemann–Stieltjes integration [37].
Let (yi, ri,m
∗
i , li, xi) denote the observed data values for the ith subject in the study and
mi denote the true value of the mediator. We use i as subject index hereafter throughout
the paper. The subjects are divided into two groups by whether M∗ is non-zero. The
first group consists of subjects whose observed value of mi is non-zero (i.e., m
∗
i 6= 0). In
this group we have m∗i = mi and the log-likelihood contribution from the ith subject can
be calculated as:
`1i = log(f(yi, ri|m∗i , xi, li)f(m∗i |xi, li)) = log(f(yi|m∗i , xi, li)f(ri|m∗i , xi, li)f(m∗i |xi, li))
= log(f(yi|m∗i , xi, li)) + log(f(ri|m∗i , li)) + log(f(m∗i |xi, li))
= −0.5 log(2pi)− log(δ)−
(
yi − β0 − β1m∗i − β2 − (β3 + β4)xi − β5xim∗i
)2
2δ2
+ log(1− P (M∗i = 0|Mi = m∗i , li)) + log((1− G(θxi))G(m∗i ; θxi)),
where f(·|m∗i , xi, li), f(·|m∗i , xi, li) and f(·|xi, li) are the (conditional) density (or proba-
bility mass function) for Y , R and M respectively. Let F (m|x) denote the (conditional)
cumulative distribution function for M . The second group consists of subjects whose
observed mi are 0 (ie, m
∗
i = 0) and their log-likelihood contribution can be calculated as:
`2i = log(f(yi, ri,m
∗
i |xi)) = log
( ∫
m∈Ω
f(yi|m,xi)f(ri|m)dF (m|xi)
)
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= log
(
G(θxi)
1√
2piδ2
exp
(
−
(
yi − β0 − β3xi
)2
2δ2
)
+
(1− G(θxi))
∫
m∈Ω\0
f(yi|m,xi)P (M∗i = 0|Mi = m))G(m; θxi)dm
)
,
where
f(yi|m,xi) = 1√
2piδ2
exp
(
−
(
yi − β0 − β1m− β2 − (β3 + β4)xi − β5xim
)2
2δ2
)
.
Taken together, we have the complete log-likelihood function given by
` =
∑
i∈group 1
`1i +
∑
i∈group 2
`2i . (7)
There is no general closed-form expression for ` due to the integration. More details
of calculating ` for ZIB mediators are given in the Appendix. We obtain the MLE of
the parameters by maximizing the above complete log-likelihood function. With the
parameter estimates, we will be able to calculate NIE, NIE1, NIE2, NDE and CDE and
their CI.
4 Simulation
Extensive simulations were carried out to demonstrate the performance of MedZIM in
comparison with three existing approaches. First, we compared MedZIM with a current
standard practice in causal mediation analyses developed by Imai, Keele and Tingley [19]
(IKT approach hereafter) which is a PO approach and can be implemented in R using the
package “mediation” [39]. The Marginal Structural Models developed in VanderWeele
[40] is also a PO approach with a very similar definition of indirect effect. These stan-
dard causal mediation analysis approaches were not developed to analyze microbiome
data, and thus could have poor performance when applied to microbiome data. Second,
MedZIM was compared with two existing approaches: CCMM [34] and SparseMCMM
[44] that were developed specifically to model microbiome composition as a mediator. In
all simulation settings, the independent variable X was binary and generated using the
Bernoulli distribution Ber(0.5) such that the number of subjects was balanced between
the two groups. The LOD mechanism in equation (6) for observing zero-valued data
points of the mediator was used to generate zeros for the mediator M . To mimic the
real study data, the library size was generated by randomly picking the library size with
replacement from a real study [2] where the library size ranges from 31,607 to 911,652.
The RA data was generated in a way such that it mimicked the distribution of RA in
real data. We generated 100 random datasets for each of the simulation settings.
4.1 Comparison with the IKT approach
In this comparison, the outcome Y was assumed to be a continuous variable and generated
using equation (1) where β5 is set to be 0 in the simulation and other true parameter
values can be found in Table 1. Similar to simulation studies in the literature [10, 11]
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where RA were generated individually, we generated an individual taxon RA with ZIB
distributions based on equation (1) and equations (3-5). The sample size was 100 in each
of the 100 random datasets. Two scenarios were considered for the taxon RA: low RA
(Scenario 1: mean of positive RA is equal to 0.0025) and high RA (Scenario 2: mean of
positive RA is equal to 0.5). About 20% of all sequencing reads were generated as true
zeros (i.e., structured zeros) in both scenarios. Under the LOD mechanism in equation
(6), about 30% sequencing reads were false zeros in Scenario 1 and there were no false
zeros in Scenario 2 because the RA in Scenario 2 was high and thus SAA were greater
than 1 for all truly non-zero RA. Model performance was evaluated by estimation bias,
standard error, coverage probability (CP) of 95% CI of the estimators for parameters and
the mediation effects in this comparison. For Scenario 1, the simulation results (Table 1)
showed good performance for MedZIM in terms of bias and CP of the mediation effects
and the parameter estimates. All the biases were small and the CP were around the
desired level of 95%. The IKT approach, however, had a poor performance with a large
bias (84.81%) and a small CP (9%). These poor performances were likely due to the false
zeros not being appropriately accounted for by the IKT approach. Another disadvantage
of IKT is that it cannot decompose the mediation effect into NIE1 and NIE2. For Scenario
2 with high RA where there were no false zeros, MedZIM showed good performance again
in terms of the performance measures. IKT also showed satisfactory performance for the
estimation of the NIE which is because there were no false zeros in the data under this
scenario, but IKT cannot decompose the mediation effect according to the zero-inflated
distribution of mediator.
Table 1: Simulation results for comparison between MedZIM and IKT with sample size
of n = 100. Bias, percentage of the bias, the empirical standard errors, the the mean of
estimated standard errors and the empirical coverage probability of the 95% CI for each
estimator is respectively reported under the columns Bias, Bias %, SE, Mean SE and
CP(%). Mediation effects from the IKT approach are provided at the bottom part of the
table.
Low relative abundance (mean=0.0025) High relative abundance (mean=0.5)
Parameter True Mean Bias Bias SE Mean CP(%) True Mean Bias Bias SE Mean CP(%)
/Effect Estimate % SE Estimate % SE
MedZIM
NIE1 0.10 0.11 0.01 10.0 0.08 0.07 91 9.30 9.11 -0.18 -1.98 2.68 2.70 96
NIE2 0.55 0.52 -0.03 -5.67 0.55 0.56 97 0.55 0.50 -0.06 -10.15 0.62 0.56 94
NIE 0.65 0.63 -0.02 -3.31 0.58 0.58 96 9.85 9.61 -0.24 -2.44 3.25 3.20 95
β0 -2.00 -2.05 -0.05 -2.45 0.32 0.33 96 -2.00 -1.92 0.07 3.82 0.32 0.29 94
β1 100.00 101.89 1.89 1.89 18.04 19.04 97 100.00 99.96 -0.04 -0.04 1.89 1.74 91
β2 4.00 4.05 0.05 1.37 0.38 0.36 94 4.00 3.93 -0.07 -1.73 0.58 0.57 91
β3 5.00 5.08 0.08 1.53 0.53 0.51 94 5.00 4.97 -0.03 -0.62 0.46 0.46 99
β4 3.00 2.93 -0.07 -2.40 0.58 0.55 92 3.00 3.02 0.02 0.55 0.53 0.54 99
δ 1.00 0.99 -0.01 -1.00 0.07 0.07 90 1.00 0.97 -0.03 -2.99 0.07 0.07 89
α0 -6.20 -6.24 -0.04 -0.69 0.36 0.36 94 -1.00 -1.01 -0.01 -0.93 0.05 0.05 90
α1 0.40 0.42 0.02 5.52 0.33 0.29 92 0.40 0.41 0.01 1.69 0.06 0.07 95
ξ 50.00 56.42 6.42 12.83 24.21 19.35 97 50.00 53.37 3.37 6.74 8.22 8.40 96
γ0 -1.16 -1.23 -0.07 -5.75 0.35 0.36 99 -1.16 -1.20 -0.04 -3.18 0.37 0.34 95
γ1 -0.50 -0.53 -0.03 -5.10 0.55 0.55 97 -0.50 -0.47 0.03 6.91 0.58 0.53 91
IKT
NIE 0.65 0.10 -0.55 -84.81 - - 9 9.85 9.20 -0.65 -6.62 - - 94
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4.2 Comparison with CCMM and SparseMCMM
In this comparison, we generated microbiome RA data with Dirichlet distributions (which
are essentially multivariate extensions of ZIB distributions) reflecting the real microbial
composition in one of our real study examples. The number of taxa and sample size
used in this simulation were similar to those in SparseMCMM [44]. Multiple testing
was adjusted using the Benjamini-Hochberg Procedure [5] in this comparison such that
the targeted FDR is 5%. The Dirichlet distribution is parameterized by the parame-
ters µ1, µ2, . . . , µK+1 and φ where µ1, µ2, . . . , µK+1 are the mean parameters of RA and∑K+1
k=1 µk = 1, and φ is the dispersion parameter. In the data generation, the mean
parameters were assumed to depend on the independent variable X through a typical
multinomial logistic regression equations:
µk =
exp (αk0 + α
k
1X)
1 +
∑K
k=1 exp (α
k
0 + α
k
1X)
, k = 1, . . . , K,
µK+1 =
1
1 +
∑K
k=1 exp (α
k
0 + α
k
1X)
.
These equations are essentially a multivariate extension of equation (3). Let α0 =
(α10, α
2
0, . . . ,
αK0 ) and α1 = (α
1
1, α
2
1, . . . , α
K
1 ). We set α
1
0 = −3.8 and all other elements of α0 were
generated from the uniform distribution U(−2,−1) and α11 = 4 and all other elements of
α1 were generated from the uniform distribution U(0, 0.6). The dispersion parameter φ
was set to be 50 to mimic overdispersion in real data. Since both CCMM and SparseMM
impute zero values with a positive number because they require all RA to be non-zero for
their analyses, we generated zero-valued data points for only the first taxon (to minimize
the imputation burden for CCMM and SparseMM) using equation (5) where γ0 = 0 and
γ1 = 2. False zeros were also generated only for the first taxon with the LOD mechanism
in equation (6) where library size was generated from the empirical distribution of library
size in the VSL#3 study data [2].
We considered two scenarios, Scenario 3 and Scenario 4, for generating Y where the
binary variable 1(M1>0) is the mediator in Scenario 3, and both 1(M1>0) and M1 are
mediators in Scenario 4. The outcome Y was generated using the following equation for
Scenario 3:
Y = β0 + β21(M1>0) + β3X + β4X1(M1>0) + , (8)
where M1 denote the RA of the first taxon, (β0, β2, β3, β4) = (−2, 6, 5, 4) and  follows the
standard normal distribution. Notice that there is only one taxon (i.e., the first taxon)
mediating the effect X on Y under this model. The outcome Y only depends on the first
taxon through the binary indicator variable 1(M1>0) which implies that NIE1 is zero in
this scenario. In the data analysis step of the simulation, MedZIM analyzed each taxon
as a mediator one by one whereas the other two approaches employed regularization
methods to handle high dimensionality. When analyzing a taxon that did not have any
zeros, MedZIM used equation (1) for the model of Y and assumed β2 = β4 = 0.
Six indices were used to evaluate the model performance: Recall, Precision, F1, bias
of the estimate of mediation effect, bias percentage and coverage probability of a 95% CI.
Recall, Precision and F1 were calculated as follows:
Recall =
TP
TP + FN
, Precision =
TP
TP + FP
, F1 =
2
1
recall
+ 1
precision
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where TP , FP , TN and FN denote true positive, false positive, true negative and
false negative respectively. Recall is a measure of statistical power, the higher the better.
Precision has an inverse relationship with false discovery rate (FDR) which is equal to (1-
Precision), and thus the higher the Precision, the lower the FDR. When FP=0, Precision
was set to be 1 regardless of whether or not TP=0. F1 is the Harmonic mean [30] of Recall
and Precision that measures the overall performance in terms of Recall and Precision.
The targeted FDR level is set to be 5% for all the three approaches in this comparison
which means that the targeted Precision is 95%. As shown in Table 2, MedZIM had good
Recall (>80%) and good F1 (>80%) for all cases except the case with sample size of 100
and 50 taxa. MedZIM either identified the only correct taxon or did not identify any
taxon at all which led to FP=0 and was why the Precision was 100% and thus it achieved
the targeted Precision of 95% for all cases. CCMM had low Recall and F1 throughout
all cases, but CCMM had Precision around the targeted Precision of 95% for most cases.
Notice that the Precision of CCMM was much higher than its Recall. This was because
CCMM did not identify any taxon most of the times and that led to FP=0 which in turn
generated high Precision. These three measures were not available for SparseMCMM
because it does not provide p-values for mediation effects of individual taxa and thus
FDR adjustment cannot be applied. The reason MedZIM had much better performance
for identifying the mediation effect is because CCMM was not developed to identify the
mediation effect of the binary change (i.e., 1(M1>0)) whereas MedZIM can accommodate
the mediation effect of 1(M1>0) induced by zero-inflated mediators. With respect to the
estimate of mediation effect, Table 2 also shows that MedZIM can provide virtually
unbiased estimates along with 95% CI that had coverage probability (CP) around the
desired level of 95% under various settings. CCMM generated large biases for its estimates
and thus the CP of 95% CI was 0%. SparseMCMM generated large biases as well. CP
is not available with SparseMCMM because it does not provide CI for any individual
taxon when its 95% CI contains 0. The observed suboptimal performance of CCMM
and SparseMCMM is probably because they were not developed to estimate the effect
mediated by the binary variable 1(M1>0) caused by the zero-inflated data structure of the
mediator whereas MedZIM can handle zero-inflated mediators reasonably well.
For Scenario 4, the outcome Y was generated using the following equation:
Y = β0 + β1M1 + β21(M1>0) + β3X + β4X1(M1>0) + . (9)
Both the continuous M1 and the binary variable 1(M1>0) were mediators in this scenario
and thus both NIE1 and NIE2 are nonzero. Notice that the only difference between the
above equation (9) and equation (8) is that β1M1 is included in equation 9 which is the
only difference between Scenario 4 and Scenario 3. The value of β1 was set to be 100 in
Scenario 4 and the values of all other parameters were set to be same as in Scenario 3.
Notice that because of the compositional structure of RA data, model (9) is equivalent
to the following model:
Y = (β0 + β1)M1 + β0
K+1∑
k=2
Mk + β21(M1>0) + β3X + β4X1(M1>0) + , (10)
where all the taxa are included and thus the compositional structure is accounted for to
some extent in model (9).
The simulation results (See Table 3) showed that MedZIM had a very good overall
performance for identifying NIE1 and NIE2 in terms of Recall (>80%), Precision (=100%)
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Table 2: Simulation results for the comparison of MedZIM with CCMM and SparseM-
CMM when the presence/absence of a taxon is the only mediator. Here n denotes the
sample size and K + 1 denotes the number of taxa. Recall, Precision, F1 and CP can-
not be extracted from SparseMCMM because it does not provide a p value for testing
individual taxa and it does not provide CI if the 95% CI contains zero.
Recall (%) Precision (%) F1 (%)
K + 1 n MedZIM CCMM SparseMCMM MedZIM CCMM SparseMCMM MedZIM CCMM SparseMCMM
(NIE2) (NIE2) (NIE2)
10 100 80 57 – 100 99 – 80 57 –
150 100 72 – 100 95 – 100 70 –
25 100 81 16 – 100 92 – 81 16 –
150 96 24 – 100 96 – 96 23 –
50 100 54 2 – 100 83 – 54 2 –
150 89 6 – 100 82 – 89 6 –
Bias Bias percentage (%) Coverage probability (%)
10 100 0.02 1.05 1.11 1.37 68.85 72.74 96 0 –
150 -0.01 1.03 1.07 -0.67 67.76 70.56 96 0 –
25 100 -0.03 1.29 1.38 -2.25 84.94 90.39 98 0 –
150 0.001 1.31 1.39 0.08 86.23 91.05 94 0 –
50 100 0.04 1.50 1.58 2.47 98.36 103.47 97 0 –
150 -0.004 1.50 1.58 -0.27 98.76 104.02 97 0 –
and F1 (>80%) for most cases except for NIE1 with sample size of 300 and 50 taxa and
NIE2 with sample size of 300 and 10 taxa. Again, MedZIM either identified the only
correct taxon or did not identify any taxon at all which led to the Precision=100% and
thus it achieved the targeted Precision of 95% for all cases. MedZIM also had a good
performance for estimating NIE1 and NIE2 in terms of bias (<0.07), bias percentage
(<4.1%) and CP (88-99%). CCMM had good performance in terms of Recall (84-98%)
and F1 (82-88%) for the cases with 10 taxa, but not for other cases. It achieved the
targeted Precision of 95% only for case with sample size of 300 and 10 taxa. The estimates
of CCMM had large bias > 94% and low CP (0-74%) throughout all the cases in Table
3. Again, the Recall, Precision, F1 and CP were not available for SparseMCMM and the
estimate of mediation effect for SparseMM had high bias (>116%). The reason CCMM
and SparseMM generated high bias in their estimates was likely because (a) CCMM
and SparseMCMM were proposed to model the RA on log-scale whereas equation (9) is
on the original scale of RA, and (b) CCMM and SparseMCMM were not developed to
incorporate the mediation effect of the binary variable 1(M1>0).
5 Real data applications
5.1 New Hampshire Birth Cohort Study (NHBCS)
The NHBCS is an NIH-funded ongoing prospective epidemiological study to investigate
the health impacts of environmental exposures with a focus on arsenic exposure in preg-
nant women and their children [15]. Pregnant women were recruited at about 24 to 28
weeks of gestational age and both mothers and babies are followed up regularly after
birth. We applied our approach in the NHBCS study to examine the mediation effect of
gut microbiome in the causal pathway from maternal arsenic exposure to infant’s health
outcomes during the first year of life. In our analysis, the total in-utero arsenic level
[31] was the exposure variable X, gut microbiome of infants at 6 weeks of age was the
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Table 3: Simulation results for the comparison of MedZIM with CCMM and SparseM-
CMM when both the presence/absence of a taxon and its abundance level are mediators.
Here n denotes the sample size and K + 1 denotes the number of taxa. Recall, Precision,
F1 and CP cannot be extracted from SparseMCMM because it does not provide a p value
for testing individual taxa and it does not provide CI if the 95% CI contains zero.
Recall (%) Precision (%) F1 (%)
K + 1 n MedZIM MedZIM CCMM SparseMCMM MedZIM MedZIM CCMM SparseMCMM MedZIM MedZIM CCMM SparseMCMM
(NIE1) (NIE2) (NIE1) (NIE2) (NIE1) (NIE2)
10 300 90 71 84 – 100 100 97 – 90 71 82 –
400 99 98 98 – 100 100 85 – 99 98 88 –
25 300 85 98 32 – 100 100 76 – 85 98 30 –
400 100 99 59 – 100 100 81 – 100 99 54 –
50 300 64 99 5 – 100 100 82 – 64 99 4 –
400 89 100 2 – 100 100 68 – 89 100 2 –
Bias Bias(%) CP (%)
10 300 -0.01 0.06 -3.41 -5.10 -0.20 4.09 -274.71 -299.23 91 94 0 –
400 -0.02 0.004 -3.43 -5.09 -0.65 0.26 -275.86 -298.14 94 97 0 –
25 300 0.01 0.01 -0.53 -0.91 0.82 0.97 -383.50 -342.89 99 91 74 –
400 0.01 0.02 -0.53 -0.93 0.91 1.43 -382.46 -350.06 96 88 65 –
50 300 -0.002 -0.002 0.76 0.67 -0.22 -0.13 94.45 125.20 97 95 29 –
400 -0.01 -0.005 0.75 0.93 -1.76 -0.32 94.09 116.30 96 96 1 –
mediator M and the outcome Y is the total number of infections treated with a pre-
scribed medicine between 4 and 12 months of age. Here X is a continuous variable and
Y is treated as a continuous variable. The gut microbiome data was measured in DNA
extracted from infant stool samples using 16S rRNA sequencing [24, 28]. After quality
control and data cleaning, there were 195 subjects and 224 genera available in the data
set. 85% of the microbiome data points were zero. Relative abundance (RA) of each
genus was analyzed as a mediator variable using a ZIB distribution. We estimated all
mediation effects (i.e., NIE1, NIE2, NIE) and their 95% CI for the exposure variable
increasing from 0 to 1 meaning x1 = 0 and x2 = 1. Notice that x1 and x2 can take other
values as needed depending on the interest of investigators. We used the BH approach [5]
for multiple-testing adjustment (targeted FDR=20%) and the 95% CI were calculated be-
fore the adjustment. We found 1 genus Fusobacterium that was statistically significantly
mediating the effect of in-utero arsenic on the infection outcome through NIE1 which
means that the RA level of Fusobacterium had a statistically significant mediation effect
but the presence of Fusobacterium did not appear to have a significant mediation effect.
The estimate for NIE1 was -0.005 (95% CI: -0.007, -0.002). Fusobacterium has been well
known to be associated with childhood infection in the literature[1, 8]. To give a full
picture of the mediation effects, a heatmap was constructed (see Figure 2) to illustrate
the NIE1 effects of all genera. IKT and CCMM did not find any significant mediation
effects of the microbial taxa. SparseMCMM is not applicable to this study because it
requires the X variable to be a binary variable.
5.2 VSL#3 mouse model
VSL#3 is a commercially available probiotic cocktail (Sigma-Tau Pharmaceuticals, Inc.)
of eight strains of lactic acid-producing bacteria: Lactobacillus plantarum, Lactobacillus
delbrueckii subsp. Bulgaricus, Lactobacillus paracasei, Lactobacillus acidophilus, Bifi-
dobacterium breve, Bifidobacterium longum, Bifidobacterium infantis, and Streptococcus
salivarius subsp. Orally administered VSL#3 has shown success in ameliorating symp-
toms and reducing inflammation in human pouchitis [18] and ulcerative colitis [35]. Pre-
ventive VSL#3 administration can also attenuate colitis in Il10-/- mice [29] and ileitis
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in SAMP1/YitFc mice [32]. When used as a preventative strategy, it has the potential
capability to prevent inflammation and carcinogenesis. In a mouse model, Arthur et al.
[2] studied the ability of a probiotic cocktail VSL#3 to alter the colonic microbiota and
decrease inflammation-associated colorectal cancer when administered as interventional
therapy after the onset of inflammation. The study duration was 24 weeks. In this study,
there were 24 mice of which 10 were treated with VSL#3 and 14 served as control. Gut
microbiome data were collected from stools at the end of the study with 16S rRNA se-
quencing. We obtained sequence data from Arthur et al. [2] and generated open reference
OTUs using the Quantitative Insights into Microbial Ecology (QIIME) [9] version 1.9.1 at
97% similarity level using the Greengenes 97% reference dataset (release 13 8). Chimeric
sequences were detected and removed using QIIME. OTUs that had 0.005% of the total
number of sequences were excluded according to Bokulich and colleagues [6]. Taxonomic
assignment was done using the RDP (ribosomal database project) classifier [45] through
QIIME with confidence set to 50%. There were 362 OTUs in total in the data sets after
quality control and data cleaning. 40% of the OTU RA data points were zero.
RA of each OTU was analyzed as a mediator variable using a ZIB distribution. The
outcome variable in our analysis was dysplasia score (the higher the worse), a continuous
variable measuring the abnormality of cell growth. The treatment variable is coded as
1/0 indicating VSL#3/control. Again, the FDR approach was used for adjusting for
multiple testing such that the targeted FDR is 20% and the 95% CI were calculated
before adjustment. Two OTUs were found to be significantly mediating the treatment
effects. One of the two OTUs was assigned to the family S24-7 under order Bacteroidales
and the other one was assigned to class Bacilli. All the significant mediation effects come
from NIE1 implying that only the mediation effects through the change in continuous
abundance scale were statistically significant. The estimates of NIE1 were 0.27 (95% CI:
0.1, 0.42) and -1.28 (95% CI: -2.06, -0.49) respectively. The family S24-7 and class Bacilli
found by our approach have also been reported to be related with colorectal cancer in the
literature [7, 33]. To give a full picture of the mediation effects in this data set, a heatmap
was constructed (see Figure 3) to illustrate the NIE1 effects of all OTUs. IKT and CCMM
did not find any significant mediation effects of the OTUs. SparseMCMM identified 18
OTUs whose (bootstrapped) 95% CI’s of their mediation effects did not contain zero,
but the widths of identified CI’s were all 0. The 18 OTUs were respectively assigned
to species distasonis, acidifaciens, farmeri, producta and muciniphila, genera Blautia,
Clostridium and Klebsiella, families S24-7 and Lachnospiraceae, Phylum Firmicutes and
Kindom Bacteria.
6 Discussion
We developed an innovative mediation modeling approach under the PO framework to
analyze mediators that have zero-inflated distributions such as the microbiome. We
showed that the mediation effect for zero-inflated mediators can be decomposed into two
components of which the first is due to the change in the mediator over its positive
domain and the second is due to the discrete binary change from zero to a non-zero
status. These two components have different interpretations and are equally important
for investigating causal mechanisms. Although the derivation of the decomposition was
done for continuous outcome variables, it can be easily extended to cases with other
types of outcome variables such as binary outcomes by employing a generalized linear
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model for Y . When the point mass G(θ) is zero for the mediator (i.e., the distribution
is not zero-inflated), the model reduces to a usual mediation analysis model. Therefore,
this approach can be also used for data sets after zero values are imputed with a positive
number or other normalization techniques are applied. Commonly used ZIB distributions
were considered for microbiome RA in this paper even though this is a fairly general
framework for mediators with zero-inflated distributions. This tool will be useful for
researchers to evaluate the mediation effects of zero-inflated mediators and disentangle
causal pathways that are scientifically important. Hence it can play an important role
in translating research findings into medical practice. R scripts for implementing the
method are available upon request.
This paper considered X as a univariate variable and did not include covariates as
potential confounders in the models. It is straightforward to adjust for a set of covariates
using our approach. Let C denote a vector of covariates or potential confounders. Then
the NIE and NDE can be calculated at a specific value, c, of C as NIE = E(Yx2Mx2 −
Yx2Mx1 |C = c), NDE = E(Yx2Mx1 − Yx1Mx1 |C = c) and CDE = E(Yx2m − Yx1m|C = c).
The value of c can be taken as the mean value of the covariates similar to how least
squares mean is calculated in regression models [17]. CI can be obtained using the delta
method or resampling methods. Decomposition of NIE follows the same procedure as
shown in Section 2.2.
Several extensions of our approach in future research are worth noting. For high-
dimensional mediators, our method can analyze the mediators one by one and employ
the BH method [5] to adjust for multiple testing. Although this can analyze the RA by
allowing a ZIB distribution for a single taxon at a time which can partially address the
compositional structure as shown in equation (10), the correlation due to hierarchical
structure of the phylogenetic tree is not utilized when the microbial taxa are analyzed
one by one. A natural extension of our approach would be to include all the taxa in a
more general model as follows:
Y =
K+1∑
k=1
βkMk + β
21(M1>0) + β
3X + β4X1(M1>0) + 
and use regularization approaches [38, 47] to select mediators for the model. Four as-
sumptions on unmeasured and measured confounders [40] are required to make causal
inference for mediation analysis. Sensitivity analysis [20, 43] can be useful to check the
robustness of model performance with respect to validation of the assumptions. Existing
sensitivity analysis procedures can be adapted in our setting for developing a sensitivity
analysis method for our approach.
Misspecification of the mechanisms for observing zero-valued data points could have
an impact on the model performance. This is similar to missing data where partial
information is available on the missing data. It can be considered as missing not at
random (MNAR) [25] because the probability of a data point being observed as zero
depends on its true value. Besides the LOD mechanism in equation 6, another possible
mechanism could be P (M∗ = 0|M,L) = exp(−ηML) where η > 0 and thus it is a
decreasing function of ML, the SAA, such that smaller values of ML are more likely to
be observed as zero. Notice that the observed value M∗ is equal to zero with probability
of one when M = 0 which corresponds to the case that M is truly zero. Model selection
approaches such BIC or AIC can be used to choose different mechanisms. Although these
mechanisms may not be perfect to account for MNAR, it can, to a large extent, alleviate
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the burden of not accounting for false zeros in the data at all. A future project has
been planned to study the robustness of our model with respect to the mechanism for
observing zeros using sensitivity analysis techniques.
7 Appendix
7.1 Mediation model for microbial relative abundance (RA)
Subject index i is suppressed in this section for simplicity. Let M denote the RA of a
microbial taxon, we use a ZIB distribution for modeling M and its two-part density can
be written as the following:
f(m; θ) =
{
G(θ), m = 0
(1− G(θ))G(m; θ), m > 0
where θ = (µ, φ,∆), G(θ) = ∆ and
G(m; θ) =
mµφ−1(1−m)(1−µ)φ−1
B
(
µφ, (1− µ)φ) , m ∈ (0, 1), 1 > µ > 0, φ > 0.
Here B(·, ·) is the Beta function and we use the mean and dispersion parameterization
for the Beta density function G(m; θ) [12, 16]. The transformation function and vectors
in equation (2) are given by: T (θ) = (log(µ/(1 − µ)), log(φ), log(∆/(1 − ∆))T , ν0 =
(α0, ξ, γ0)
T and ν1 = (α1, 0, γ1)
T . We use identity link for g(·) in equation (1) since Y is
a continuous outcome, and thus the mediation model consists of the following equations:
Y = β0 + β1M + β21(M>0) + β3X + β4X1(M>0) + β5XM + 
log
( µ
1− µ
)
= α0 + α1X,
log (φ) = ξ,
log
(
∆
1−∆
)
= γ0 + γ1X.
Let ζ = (β0, β1, β2, β3, β4, β5, δ, α0, α1, ξ, γ0, γ1)
T . The formulas for NIE, NIE1, NIE2,
NDE and CDE are given below where NIE1, NIE2, NDE and CDE can be considered as
functions of the parameter vector ζ:
NIE = E(Yx2Mx2 − Yx2Mx1 )
= E((β1 + x2β5)(Mx2 −Mx1) + (β2 + x2β4)(1(Mx2>0) − 1(Mx1>0)))
= (β1 + x2β5)(E(Mx2)− E(Mx1)) + (β2 + x2β4)(E(1(Mx2>0))− E(1(Mx1>0)))
= NIE1 + NIE2,
NIE1 = f1(ζ)
= (β1 + x2β5)
(
expit(α0 + α1x2)− expit(α0 + α1x1)
)
− (β1 + x2β5)
(
expit(γ0 + γ1x2)expit(α0 + α1x2)
− expit(γ0 + γ1x1)expit(α0 + α1x1)
)
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NIE2 = f2(ζ)
= (β2 + x2β4)
(
expit(γ0 + γ1x1)− expit(γ0 + γ1x2)
)
NDE = f3(ζ)
= E
(
Yx2Mx1 − Yx1Mx1
)
= (β3 + β4E(1(Mx1>0)) + β5E(Mx1))(x2 − x1)
=
(
β3 + β4expit(γ0 + γ1x1) + β5(1− expit(γ0 + γ1x1))expit(α0 + α1x1)
)
(x2 − x1)
CDE = f4(ζ)
= E
(
Yx2m − Yx1m
)
=
(
β3 + β41(m>0) + β5m
)
(x2 − x1).
7.2 Log-likelihood function under the LOD mechanism for ob-
serving zero values
Let (yi, ri,m
∗
i , xi, li) denote the observed data for the ith subject where li is the observed
library size. If the ith subject is in the first group, its log-likelihood contribution can be
calculated as:
`1i = log(f(yi, ri|m∗i , xi,Li)f(m∗i |xi, li)) = log(f(yi|m∗i , xi, li)f(ri|m∗i , xi, li)f(m∗i |xi, li))
= log(f(yi|m∗i , xi, li)) + log(f(ri|m∗i , li)) + log(f(m∗i |xi, li))
= − log(δ)−
(
yi − β0 − β1m∗i − β2 − (β3 + β4)xi − β5xim∗i
)2
2δ2
+ log(1−∆i)− log
(
B
(
µiφ, (1− µi)φ
))
+ (µiφ− 1) log (m∗i ) +
(
(1− µi)φ− 1
)
log (1−m∗i ) + cons,
where ∆i = expit(γ0 + γ1xi), µi = expit(α0 + α1xi) and φ = exp (ξ). If the ith subject is
in the second group, its log-likelihood contribution can be calculated as:
`2i = log(f(yi, ri,m
∗
i |xi)) = log
( 1/li∫
0
f(yi, ri|m,xi)dF (m|xi)
)
= log
(∫ 1
0
f(yi|m,xi)f(ri|m)dF (m|xi)
)
= log
(
∆i√
2piδ2
exp
(
− (yi − β0 − β3xi)
2
2δ2
)
+
1/li∫
0
f(yi|m,xi)(1−∆i)m
µiφ−1(1−m)(1−µi)φ−1 exp(−ηmli)
B
(
µiφ, (1− µi)φ
) dm)
= − log(δ) + log
(
∆i exp
(
− (yi − β0 − β3xi)
2
2δ2
)
+
1−∆i
B
(
µiφ, (1− µi)φ
) 1/li∫
0
hi(m)dm
)
+ cons,
where
hi(m) =m
µiφ−1(1−m)(1−µi)φ−1
17
× exp
(
−
(
yi − β0 − β1m− β2 − (β3 + β4)xi − β5xim
)2
2δ2
)
.
Taken together, the complete log-likelihood function can be calculated as
`ZIB =
∑
i∈group 1
`1i +
∑
i∈group 2
`2i .
7.3 Delta method for obtaining 95% CI of NIE1, NIE2, NDE
and CDE
Since NIE1, NIE2, NDE and CDE can be treated as functions of the parameter vector ζ
as shown in Section 7.1, it suffices to derive the 95% CI for f1(ζˆ), f2(ζˆ), f3(ζˆ) and f4(ζˆ)
where ζˆ is the MLE of ζ. We first calculate the observed Fisher information matrix which
can be calculated as Iobs = −∂2`ZIB∂ζ∂ζT |ζ=ζˆ where `ZIB is the log-likelihood function derived
in Section 7.2. By using the multivariate Delta method, we can calculate the variance of
the estimates as follows:
var(NIE1) = var(f1(ζˆ)) =
(
∂f1(ζ)
∂ζ
|ζ=ζˆ
)T
var(ζˆ)
(
∂f1(ζ)
∂ζ
|ζ=ζˆ
)
=
(
∂f1(ζ)
∂ζ
|ζ=ζˆ
)T
I−1obs
(
∂f1(ζ)
∂ζ
|ζ=ζˆ
)
,
where ∂f1(ζ)
∂ζ
=
(
∂f1(ζ)
∂β0
, ∂f1(ζ)
∂β1
, . . . , ∂f1(ζ)
∂γ1
)T
. Let z0.025 denotes the 97.5th percentile of
the standard normal distribution and the 95% CI of NIE1 can calculated as
(
f1(ζˆ) −
z0.025
√
var(f1(ζˆ)), f1(ζˆ) + z0.025
√
var(f1(ζˆ))
)
. The 95% CI for NIE2, NDE and CDE can
be calculated similarly.
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Figure 2: Heatmap of mediation strength based on NIE1 in NHBCS study. The mediation
strength is measured by (1-p) where p is the unadjusted p-value. Negative sign indicates
negative NIE1. Genera are labeled on the vertical axis and samples are labeled on the
horizontal axis. Absence of a genus in a sample is coded as 0 in the heatmap.
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Figure 3: Heatmap of mediation strength based on NIE1 in VSL#3 study. The mediation
strength is measured by (1-p) where p is the unadjusted p-value. Negative sign indicates
negative NIE1. Taxonomic assignment is labeled on the vertical axis. Samples are labeled
on the horizontal axis. Absence of an OTU in a sample is coded as 0 in the heatmap.
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